# Humira

Type: Product

Source: Healthcare Intelligence Brief — https://gethealthbrief.com/entity/humira
Canonical HTML page: https://gethealthbrief.com/entity/humira

## Timeline

- **2029-01-01**: Operational Launch — The North Chicago facilities are expected to begin full-scale API production.
- **2026-03-20**: Construction Start — Groundbreaking expected for the two new advanced manufacturing sites.
- **2026-02-23**: Manufacturing Expansion — AbbVie announces $380M investment for North Chicago API facilities.
- **2026-01-12**: $100B Pledge — AbbVie commits to $100 billion in U.S. R&D and manufacturing over the next decade.

## Recent coverage (1 stories)

### AbbVie Commits $380M to U.S. Manufacturing Amid $100B Domestic Pivot
2026-02-25 00:14:05 · Sentiment: Positive · Impact: 7/10 · Sources: 3

AbbVie has announced a $380 million investment to expand its North Chicago manufacturing campus, marking the first major step in a $100 billion decade-long commitment to U.S. R&D. The initiative aims to localize active pharmaceutical ingredient production while integrating with the Trump administration's 'TrumpRx' program to lower drug costs.
Full story: https://gethealthbrief.com/story/abbvie-380m-us-manufacturing-investment

---
This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://gethealthbrief.com/guides/methodology for the full editorial methodology.